Bladder cancer is the most common malignancy of the urinary tract. Cystoscopy represents
the gold standard in the diagnosis of suspicious bladder lesions. However, the procedure is …

Bladder cancer (BC) is characterized by high incidence and recurrence rates together with
genomic instability and elevated mutation degree. Currently, cystoscopy combined with …

Simple Summary The clinical management of bladder cancer has been developing in the
past decade, including diagnostic tools and treatment options. Both monotherapy and …

Background Current non-invasive tests have limited sensitivities and lack capabilities of pre-
operative risk stratification for bladder cancer (BC) diagnosis. We aimed to develop and …

Simple Summary Urinary bladder cancer is one of the ten major cancers worldwide, with
higher incidences in males, in smokers, and in highly industrialized countries. New …

Bladder cancer is the 10th most common cancer type worldwide. Cystoscopy represents the
gold standard for bladder cancer diagnosis, but this procedure is invasive and painful …

Background Better prognostic outcome is closely correlated with early detection of bladder
cancer. Current non-invasive urianalysis relies on simultaneously testing multiple …

Patients with non-muscle invasive bladder cancer (NMIBC) have high recurrence and
progression rates in spite of tumor resection and adjuvant instillation therapy. To detect …

Simple Summary Bladder cancer (BC) is a common cancer that causes high morbidity and
mortality among affected patients. As a carcinogen-driven cancer, molecular oncology of BC …

Bladder cancer is a common urinary tract cancer with a difficult clinical course. With frequent
recurrence, patients with a history of bladder cancer often undergo surveillance that involves …